Judge Orders Mallinckrodt Trial On Acthar Antitrust Claims
A Delaware bankruptcy judge on Wednesday rejected drugmaker Mallinckrodt PLC's bid to block insurer demands for full post-petition, administrative priority payment of monopoly-inflated costs for a drug used to treat infantile spasms,...To view the full article, register now.
Already a subscriber? Click here to view full article